Sanofi SNY
NASDAQ SNY
$48.39 +0.02 (+0.04%)
At close: Nov 16, 2026 · 4:00 PM EST

Sanofi (SNY) Income from Continuing Operations (2009 - 2026)

Updated

Sanofi (SNY) posted Income from Continuing Operations of $5.75 billion for Q3 2026, up 74.0% from $3.31 billion a year earlier.

Analysis

Sanofi (SNY) Income from Continuing Operations (2009 - 2026) Analysis & Trends

For the trailing twelve months through Sep 30, 2026, Income from Continuing Operations at Sanofi was $7.12 billion, down 1.8% year-over-year; for FY2025, it was $5.62 billion, down 6.5% from FY2024.

  • Annual Income from Continuing Operations shows a five-year compound annual growth rate of -16.8% (FY2020 to FY2025).
  • In prior years, Sanofi's Income from Continuing Operations was $6.01 billion in FY2024 (+9.0%), $5.51 billion in FY2023 (-35.3%), $8.52 billion in FY2022 (+14.6%) and $7.43 billion in FY2021 (-47.2%).
  • The Q3 2026 figure stands as the highest quarterly Income from Continuing Operations since Q2 2020.
  • On a year-over-year basis, Income from Continuing Operations increased in five of the last seven quarters, with growth averaging 5.9%.
  • The strongest year-over-year quarter for Income from Continuing Operations in the past five years was Q2 2024, with growth of 312.5%; the weakest was Q1 2024, with a decline of 69.2%.
  • According to Business Quant data, Income from Continuing Operations for the three prior quarters was $438.21 million (Q2 2026), $1.87 billion (Q1 2026) and -$939.38 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 6.45 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 210.00 Mn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 4.22 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 5.07 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 4.80 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 3.86 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 2.43 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 3.25 Bn
10 Sanofi 59.05 Bn 29.25 Bn 33.35 Bn 5.75 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 5.75 Bn
Jun 30, 2026 438.21 Mn
Mar 31, 2026 1.87 Bn
Dec 31, 2025 -939.38 Mn
Sep 30, 2025 3.31 Bn
Jun 30, 2025 1.40 Bn
Mar 31, 2025 1.81 Bn
Dec 31, 2024 736.26 Mn
Sep 30, 2024 3.08 Bn
Jun 30, 2024 1.15 Bn
Mar 31, 2024 1.07 Bn
Dec 31, 2023 2.04 Bn
Sep 30, 2023 4.61 Bn
Jun 30, 2023 279.85 Mn
Mar 31, 2023 3.49 Bn
Dec 31, 2022 5.39 Bn
Sep 30, 2022 3.51 Bn
Jun 30, 2022 375.60 Mn
Mar 31, 2022 3.17 Bn
Dec 31, 2021 289.88 Mn
API Access

Sanofi Income from Continuing Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=SNY&period=max&api_key=YOUR_API_KEY